Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical Antipsychotics.

Pesa, Jacqueline A; Muser, Erik; Montejano, Leslie B; Smith, David M; Meyers, Oren I

Pesa, Jacqueline A; Muser, Erik; Montejano, Leslie B; Smith, David M; Meyers, Oren I.

Afiliação

Pesa JA; Janssen Scientific Affairs, LLC, 3133 Castle Peak Ave. Superior, Louisville, CO 80027 USA.
Muser E; Janssen Scientific Affairs, LLC, 3133 Castle Peak Ave. Superior, Louisville, CO 80027 USA.
Montejano LB; Truven Health Analytics, Cambridge, USA.
Smith DM; Truven Health Analytics, Cambridge, USA.
Meyers OI; Truven Health Analytics, Cambridge, USA.

Drugs Real World Outcomes ; 2(4): 377-385, 2015.

Article em En | MEDLINE | ID: mdl-26689953

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Observational_studies / Prognostic_studies Idioma: En Revista: Drugs Real World Outcomes Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google